Guided Therapeutics (OTCMKTS:GTHP) and NeurAxis (NASDAQ:NRXS) Critical Review
Profitability This table compares NeurAxis and Guided Therapeutics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets NeurAxis -492.76% N/A -641.25% Guided Therapeutics N/A N/A -151.93% Insider & Institutional Ownership 11.8% of NeurAxis shares are held by institutional investors. Comparatively, 9.7% of Guided Therapeutics shares are held […]
Profitability This table compares NeurAxis and Guided Therapeutics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets NeurAxis -492.76% N/A -641.25% Guided Therapeutics N/A N/A -151.93% Insider & Institutional Ownership 11.8% of NeurAxis shares are held by institutional investors. Comparatively, 9.7% of Guided Therapeutics shares are held […]
